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Which derivative from overnight oximetry best
predicts symptomatic response to nasal continuous
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The cost and inconvenience of polysomnography for the investigation of obstructive sleep apnoea (OSA) has led to
the search for simpler and cheaper alternatives. These are usually compared to an apnoea/hypopnoea index (AHI)
derived from oro-nasal airflow and ribcage/abdominal eort sensors. However, AHI is not a proven gold standard
for the identification of clinically important OSA. Recent work has shown that correctly analysed oximetry indices
not only mimic AHI with considerable accuracy, but also predict the symptomatic response to nasal continuous
positive airway pressure (nCPAP) at least as well as conventional polysomnographic indices. This current study
looks at 10 dierent derivatives of all-night oximeter tracings in 81 patients with OSA, and compares their ability to
predict the improvement in subjective sleepiness after 6 months of nCPAP therapy.
Sleep apnoea in this study was defined as a 44% SaO2 dip rate of 410 h
71, and an Epworth sleepiness score
(ESS) of 410 on presentation. Subjects took part in a placebo-controlled trial of nCPAP for 1 month and
thereafter were all supplied with nCPAP set at an eective pressure. All night SaO2 was sampled every 2 sec and
later analysed for mean, median, mean nadir of SaO2 dip, time below 90%, 2 and 12 sec delta index (an average
measure of SaO2 change across these two time periods), rapid resaturation index (rises in SaO243% within 10 sec
per hour), and 44, 43, and 42% dips per hour. These indices were then correlated with the change in ESS seen
after 6 months on nCPAP
Median compliance for the group was 5?8 (5/95% range, 1?5–8?0) h night71. The two best correlates of
improvement in ESS were the 44% SaO2 dips h
71 (Spearman’s r=70?33 P=0?002) and the delta 12 sec index
(r=70?33, P=0?003). Cumulative time below 90% SaO2 was almost as good (r=70?29, P=0?009). The worst
correlate was the 42% SaO2 dips h
71 (r  0?01, not significant).
This study has identified which of several analyses of overnight oximeter recordings best identify nCPAP
responsive OSA. Both 44% SaO2 dips and 12 sec delta index are equally predictive and presumably the most
appropriate derivatives to calculate from overnight records of SaO2.
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Overnight oximetry is increasing in popularity as a
diagnostic test for obstructive sleep apnoea (OSA) (1–8).
Such tests are inexpensive, can be performed either in
hospital or at home, and are easily processed by computer
to give reproducible and objective results. Most authors
have found a reasonable agreement between oximetry
indices and the supposed gold standard, the apnoea/Received 24 November 1999 and accepted in revised form 10 April
2000.
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0954-6111/00/090895+05 $35?00/0hypopnoea index (AHI), measured during conventional
polysomnography using oro-nasal airflow and ribcage/
abdominal eort sensors (2–4,6,9,10), However, polysom-
nographic indices (both respiratory and neurophysiologi-
cal) correlate poorly with symptoms of OSA. This makes
them only semiquantitative in their ability to assess the
clinical severity of OSA (11–13), calling into question the
use of AHI as a gold standard against which to assess other
potential diagnostic techniques (14–15).
Our laboratory has previously used an outcome measure,
the symptomatic improvement following nasal continuous
airway pressure (nCPAP), as a tool to assess which
physiological signals are best at measuring that proportion
of a patient’s symptoms resulting form sleep fragmentation
(due to upper airway narrowing or collapse during sleep)
(12). Using this approach, it was established that the# 2000 HARCOURT PUBLISHERS LTD
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71 performed at least as well as
conventional indices of OSA severity (AHI, micro arousal
index) in predicting the symptomatic response to nasal
CPAP at 1 month. In this study the correlation between
AHI and 44% SaO2 dips h
71 was 0?89 (10). This previous
study (12), however, looked only at one oximetric index,
44% SaO2 dips h
71, and did not evaluate alternative
oximeter analyses (1,2,5,6).
The data available from a previous randomized placebo
controlled study (RCT) carried out in our department has
allowed us to look to the ability of a variety of oximeter
analyses to predict symptomatic response to nCPAP at 6
months in a larger group of patients with moderate to
severe OSA. This simple analysis should allow the
identification of the most appropriate oximetric index to
calculate routinely from overnight recordings of SaO2.
Methods
SUBJECTS
All the patients in this study were men recruited into a
previously reported RCT of nCPAP (16,17). This was a
parallel design with either placebo or real nCPAP for a
month and then all patients received real nCPAP for the
next 5 months before their final assessment. Patients
entering the study were referred for the investigation of
possible OSA and had not previously received nCPAP or
other treatment for OSA. A diagnostic sleep study was
performed (Visi-lab, Stowood Scientific Instruments, Ox-
ford, U.K.) which measured body movements and heart
rate as indices of sleep fragmentation, in addition to
oximetry and snoring as indices of ventilatory impairment
(12). An all night video recording was also available for
direct inspection. Entry criteria for the original RCT
required a 44% SaO2 dip rate of more than 10 per hour,
an Epworth Sleepiness Score in the clinic of 410, and a
willingness to give up the extra time involved in the study.
TECHNIQUES
Assessment of sleepiness
All subjects repeated the Epworth Sleepiness Score (ESS)
on the day of the baseline measurements, and again at 6
months (18). The ESS is a well validated technique for
assessing subjective sleepiness and consists of an eight-item
questionnaire asking about the tendency to fall asleep in
various situations. Each item is scored 0 to 3 and the final
score is a simple total where 0 indicates no sleepiness, and
24 is maximally sleepy.
Oximetry
As part of the initial sleep study, Biox 3700 oximeters
(Ohmeda, Boulder, CO, U.S.A.) were used with finger
probes. The analogue output was sampled every 2 sec
throughout. Apart from disabling the internal alarm, theoximeters were not modified in any way. Prior to
subsequent analysis, periods of clear artefact were removed.
These usually consisted of periods with very poor signal,
identified from an apparent chaotic pulse rate, or when the
probe was removed from the finger.
Ten dierent analyses were performed. The all night
mean and median SaO2 were calculated, the cumulative
time spent below 90% SaO2 (5,19), and the mean of all the
lowest SaO2 values reached during each 4% dip, ‘mean
nadir’ (20). In addition two delta indices were calculated
(1,20). The calculation of these indices involved subtracting
each SaO2 value from the one before and quoting the mean
of the absolute dierences for the whole night. The more
the SaO2 oscillates, the larger the value. The mean value
(delta index) is thus an estimate of the changes occurring
within a certain time frame, which is set by the chosen time
interval between sampling points. We used both 2 sec and
12 sec intervals. Two seconds was our actual sampling
frequency, and 12 sec is the sampling interval used by the
Ohmeda 3700 oximeter when it is storing to its internal
memory (20). Many centres use the storage facility of this
oximeter for home studies and thus only have access to the
12 sec data. The 3700 oximeter actually stores at the end of
each 12 sec the lowest value that occurred in the previous
12 sec. This algorithm has been shown to follow the
oscillating SaO2 found in patients with OSA with reason-
able accuracy (21) and was mimicked in our analysis. We
also used the analysis of Rauscher et al. which looks mainly
at rapid SaO2 resaturations on the grounds that these occur
when a patient wakes and restores their SaO2. By looking at
43% rises within the time frame of 10 sec, slower rises in
SaO2 are not documented (2).
Finally, we included the more conventional oximetry
analysis, using the identification of dips in SaO2 of more
than a certain size (22). This analysis can be varied in a
number of ways that will influence the result considerably.
Of particular importance is the definition of the value below
which a dip in SaO2 is identified. Some authors have used
moving window means (that will be influenced by the dips
themselves), some use the upper centiles (e.g. 90th) of the
moving window (to try and represent the ‘unobstructed’
SaO2), and others have simply used a fixed value, such as
94%. The approach we have used is a simple algorithm that
looks for a figure 44% lower than the previous con-
tinuously updated high. When this condition is met, the dip
counter is incremented, and no further dip can be counted
until the SaO2 has risen again by 43%. Thus the actual
baseline does not matter, and this approach assumes that
any fall in SaO2 is due to a reduction in ventilation of a
certain amount, and any rise a resumption. The threshold
for defining a dip can be reduced to 43% or 42%, when
the recovery requirement to reset the counter is 42% or
41% respectively. The smaller the dip registered, the more
‘noise’ will be logged by the algorithm.
PROTOCOL
Following their diagnostic sleep studies, 107 patients were
recruited into the study from the outpatient clinic. They
TABLE 1. Characteristics of the patients with OSA in the
study group
n  81 Median 5%/95%
range
Age (years) 50?0 35?0/68?0
BMI (kg m72) 35?0 26?1/49?2
44% SaO2 dips/hour 31?5 8?6/76?0
Epworth Sleepiness Scale (ESS) 15?0 9?0/22?9
Change in ESS at 6 months
following nasal CPAP
710?0 719?0/2?1
PREDICTION OF SYMPTOMATIC RESPONSE TO NCPAP IN OSA 897completed a repeat ESS to provide a baseline value, during
the study day prior to starting nCPAP that evening. Half
the subjects received real titrated nCPAP (23), and half
placebo (1cmH2O) for 1 month (16). At the end of 1 month,
101 patients were put on to real titrated nCPAP. At the end
of 6 months, all patients were asked to return for a repeat
ESS measurement. Compliance with nCPAP was also
measured in all subjects from the built-in time clocks.
ANALYSIS
Some of the sleep study indices were not normally
distributed and all results are described using the median
and 5–95% range. The improvements in ESS at 6 months
were calculated for each individual. These ESS improve-
ments were then correlated with each of the baseline
oximetric indices and the P-values calculated (Spearman’s







44% SaO2 dips h
71 31?5 8?6/76?0
43% SaO2 dips h
71 42?7 20?1/81?3
42% SaO2 dips h
71 75?3 43?2/95?4
Mean %SaO2 91?1 80?4/94?6






(% of analysis interval)
25?3 2?9/82?8
12 sec delta index 2?4 1?1/5?6
2 sec delta index 0?92 0?55/1?61
Rapid resaturation
index (43% per h)
52?3 20?5/84?7Results
Eighty-eight patients returned for the final measurements at
6 months, but parts of the data were incomplete in seven
patients. Therefore there were 81 in the study group for this
analysis, Table 1 shows the characteristics of this group.
The median compliance with nCPAP during the 6 months
was 5?8 (5/95% range, 1?5–8?0) h night71. Table 2 shows
the median values for each of the 10 pre-treatment
oximetric indices, and their individual correlations with
the change in ESS following nCPAP. The four best
predictors of improvement in sleepiness are the 44% and
43% dips, the 12 sec delta index, and the cumulative time
spent below 90% SaO2. The worst was 42% dips,
presumably due to the incorporation of considerable
‘noise’.
Discussion
This study has shown that a number of measures derived
from oximetry predict improvement of sleepiness in
patients with OSA following treatment with nCPAP. Some
of the analyses perform equally well, with 44% SaO2 dips
being marginally (though not significantly) the best. The
entry criteria for this study required symptoms (ESS410)
and moderate/severs OSA (44% SaO2 dips h
71410), and
thus our findings might not necessarily apply to patients of
lower severity, or to asymptomatic subjects.
We have chosen to use improvement in ESS with nasal
CPAP as our ‘gold standard’ way of assessing the
usefulness of a test for quantifying OSA and its variants.
Baseline sleepiness will of course be contaminated with
all the other factors provoking daytime sleepiness that are
not related to OSA, such as sleep time, depression androvement in sleepiness forllowing nasal CPAP
pearman’s correlation
oecient with change














898 S. CHOI ET AL.caeine consumption, to name but a few. By looking at
improvements in sleepiness following nCPAP, we are
isolating the component of the patient’s symptoms due
presumably to sleep fragmentation provoked by upper
airway narrowing or collapse. In previous publications we
have argued the rationale behind this approach, and
currently there seems no better way of validating the
clinical value of a test for OSA and its variants (12,14).
Although micro-arousal indices and AHI are extensively
used, their utility in clinical practice has rarely been
assessed, and our previous data clearly shows they are no
better than 44% SaO2 dip rate at predicting nCPAP
response (12). In this previous study, compared to baseline
sleepiness, a greater proportion of the change in sleepiness
following nCPAP could be predicted from sleep study
indices measuring respiratory events. This suggested
that improvement in symptoms following nCPAP is a
better outcome measure for assessing diagnostic ap-
proaches than baseline sleepiness. However, symptomatic
responses to nasal CPAP will themselves be contaminated
to some extent by other factors, such as nCPAP
compliance (24), the initial symptom severity, the placebo
component of the response (16), and any detrimental eects
of nasal CPAP. Indeed, the best oximetric index in this
study only explained 12% of the variance in ESS
improvement.
This study has confirmed that oximetric indices do
partially predict response to nCPAP in subjects with
moderate to severe OSA, who were willing to try this
treatment for their symptoms. However, the various
oximetric indices proposed do not all perform equally well,
with 44% SaO2 dip rate and the 12 sec delta index
predicting best the symptomatic response to nCPAP. These
two are therefore presumably the most appropriate
derivatives to calculate from overnight records of SaO2.
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